• Canuck@sh.itjust.works
    link
    fedilink
    English
    arrow-up
    2
    arrow-down
    7
    ·
    1 year ago

    Only point I’d add is drugs cost more than they are to produce because of R&D costs, which must be recuperated. If costs are high, and volume is low, it means larger markup over the cost to manufacture.

    • nickwitha_k (he/him)@lemmy.sdf.org
      link
      fedilink
      English
      arrow-up
      6
      arrow-down
      1
      ·
      1 year ago

      The R&D costs were largely already paid by tax-payer funded research grants and, in this case, additional emergency funding from governments. This is especially the case in the US, where the government is also legally required to hand over patents for government developed drugs to private companies that did none of the work.